71 filings
8-K
STRO
Sutro Biopharma Inc
13 May 24
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
8-K
STRO
Sutro Biopharma Inc
2 Apr 24
Entry into a Material Definitive Agreement
5:10pm
8-K
STRO
Sutro Biopharma Inc
2 Apr 24
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
6:04am
8-K
STRO
Sutro Biopharma Inc
25 Mar 24
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
8-K
STRO
Sutro Biopharma Inc
9 Feb 24
Other Events
4:27pm
8-K
su7hf3ga8qu
8 Jan 24
Results of Operations and Financial Condition
7:31am
8-K
ggmekz8j
27 Nov 23
Entry into a Material Definitive Agreement
4:05pm
8-K
e7heqfgg
21 Nov 23
Departure of Directors or Certain Officers
4:05pm
8-K
j9k7lb5n
13 Nov 23
Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
8-K
b3ma1 ha63
4 Oct 23
Entry into a Material Definitive Agreement
4:31pm
8-K
54v29obo
10 Aug 23
Sutro Biopharma Reports Second Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:31pm
8-K
g8h qt9q9rt
26 Jun 23
Entry into a Material Definitive Agreement
8:01am
8-K
n21of5x
14 Jun 23
Termination of a Material Definitive Agreement
4:31pm
8-K
hdxt xn7481dlyb
15 May 23
Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
8:01am
8-K
8e5606f
27 Apr 23
Departure of Directors or Certain Officers
4:31pm
8-K
hp2bve9t4bpf
14 Apr 23
Departure of Directors or Certain Officers
4:06pm
8-K
ysxnx0f ibr7akyp
30 Mar 23
Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones
4:32pm
8-K
lnpbbhdc7rp3h6jqlwag
24 Feb 23
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
2ev5xx4 gime2
9 Jan 23
Regulation FD Disclosure
5:15pm
8-K
rws 4y6zz
20 Dec 22
Entry into a Material Definitive Agreement
4:07pm